![Li Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 786 M $ al 31/05/2026
Li Li es un empresario que fundó Shenzhen Hepalink Pharmaceutical Group Co., Ltd. y que ha estado al frente de 5 empresas diferentes. En la actualidad, es presidente de Shenzhen Techdow Pharmaceutical Co., Ltd. y presidente de Shenzhen Hepalink Pharmaceutical Group Co., Ltd., presidente y director general de Hepalink USA, Inc. y presidente de Shenzhen Duopule Industrial Development Co., Ltd. (ambas son filiales de Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). También forma parte del consejo de Cytovance Biologics, Inc. (ex presidente), Shenzhen Leren Technology Co. Ltd. y Urumqi Feilaishi Equity Investment Co. Ltd. El Sr. Li se licenció en la Universidad de Sichuan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 514.349.899 ( 41,24 % ) | 755 M $ | 31/05/2026 | |
HIGHTIDE THERAPEUTICS INC 13,62 % | 30/06/2025 | 77.804.710 ( 13,62 % ) | 30 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Fundador | 21/04/1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Director/Miembro de la Junta | - |
Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Miembro de la Junta | - |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Presidente | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Director Ejecutivo | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Presidente | 13/01/2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Director/Miembro de la Junta | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Miembro de la Junta | 02/02/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Sichuan University
 Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Technology Services |
Urumqi Feilaishi Equity Investment Co. Ltd. | |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Hightide Therapeutics, Inc.
 Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
